Publications by authors named "Anna Garcia-Sangenis"

Objective: To evaluate the effect of effervescent paracetamol on office and ambulatory blood pressure (BP) compared with noneffervescent paracetamol in hypertensive patients.

Design: This was a multicenter open crossover randomized clinical trial.

Setting: Primary care centers in Catalonia and the Basque Country.

View Article and Find Full Text PDF

Introduction: Community-acquired pneumonia (CAP) is treated with penicillin in some northern European countries.

Objectives: To evaluate whether high-dose penicillin V is as effective as high-dose amoxicillin for the treatment of non-severe CAP.

Design: Multicentre, parallel, double-blind, controlled, randomized clinical trial.

View Article and Find Full Text PDF

Background: Streptococcus pneumoniae is the bacterial agent which most frequently causes pneumonia. In some Scandinavian countries, this infection is treated with penicillin V since the resistances of pneumococci to this antibiotic are low. Four reasons justify the undertaking of this study; firstly, the cut-off points which determine whether a pneumococcus is susceptible or resistant to penicillin have changed in 2008 and according to some studies published recently the pneumococcal resistances to penicillin in Spain have fallen drastically, with only 0.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Anna Garcia-Sangenis"

  • Anna Garcia-Sangenis's research focuses on evaluating the efficacy and safety of different antibiotic treatments and analgesics in clinical settings, particularly concerning their effects on conditions like hypertension and pneumonia.
  • In a crossover randomized clinical trial, she examined the impact of effervescent paracetamol on blood pressure in hypertensive patients, revealing important clinical insights into analgesic use in this demographic.
  • Additionally, her investigation into the effectiveness of high-dose penicillin compared to amoxicillin for treating community-acquired pneumonia highlights the potential for optimizing antibiotic use in primary care, particularly amid rising antibiotic resistance.